Concepedia
Statistics
Publications
21
Citations
2.2K
H-Index
20
Active since
2016
Affiliations
Center for Drug Evaluation and Research(Current)
United States Food and Drug Administration
Center for Devices and Radiological Health
Jingyu Yu is an author at Center for Drug Evaluation and Research specializing in medicine, oncology, and cancer therapeutics.
Top concepts
MedicineOncologyCancer TherapyPharmacotherapyPharmacologyCancer ResearchClinical TrialsUrologyImmunologyMolecular Oncology
Publications per year
2016–2024
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond
Lee H. Pai-Scherf, Gideon M. Blumenthal, Hongshan Li et al. · The Oncologist · 2017 · 286 citations · Full text
FDA Approval Summary: Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy
Erin Larkins, Gideon M. Blumenthal, Weishi Yuan et al. · The Oncologist · 2017 · 210 citations · Full text
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
Elaine Chang, Chana Weinstock, Lijun Zhang et al. · Clinical Cancer Research · 2020 · 173 citations · Full text
Peripheral Neuropathy, Urology, Seattle Genetics +14
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer
Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 158 citations
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer
Preeti Narayan, Tatiana M. Prowell, Jennifer Gao et al. · Clinical Cancer Research · 2020 · 157 citations · Full text
1–5 of 21